ProfileGDS4718 / 208760_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 72% 77% 97% 78% 80% 83% 82% 78% 81% 75% 79% 83% 69% 88% 78% 73% 82% 81% 81% 76% 77% 80% 78% 78% 76% 90% 84% 89% 77% 85% 79% 91% 75% 64% 91% 88% 89% 81% 81% 96% 78% 85% 86% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.0364872
GSM549102patient 115, normal, homogenized [OPG study]7.4216977
GSM549104patient 119, normal, homogenized [OPG study]10.780397
GSM549108patient 138, normal, homogenized [OPG study]7.4966378
GSM549119patient 077, normal, homogenized [OPG study]7.7971980
GSM549133patient 032, cancer, homogenized [OPG study]8.3797983
GSM549139patient 042, cancer, homogenized [OPG study]8.0972282
GSM549099patient 107, normal, homogenized [OPG study]7.5191478
GSM549109patient 139, normal, homogenized [OPG study]7.916581
GSM549110patient 046, normal, homogenized [OPG study]7.2634975
GSM549114patient 063, normal, homogenized [OPG study]7.7403879
GSM549122patient 082, normal, homogenized [OPG study]8.1787683
GSM549134patient 033, cancer, homogenized [OPG study]6.7610869
GSM549136patient 036, cancer, homogenized [OPG study]9.004488
GSM549140patient 044, cancer, homogenized [OPG study]7.6991878
GSM549111patient 047, normal, homogenized [OPG study]7.1823473
GSM549113patient 057, normal, homogenized [OPG study]8.1598982
GSM549132patient 031, cancer, homogenized [OPG study]7.9845881
GSM549137patient 038, cancer, homogenized [OPG study]8.0564681
GSM549142patient 047, cancer, homogenized [OPG study]7.3153976
GSM549100patient 110, normal, homogenized [OPG study]7.4337877
GSM549107patient 135, normal, homogenized [OPG study]7.9190580
GSM549115patient 068, normal, homogenized [OPG study]7.7300778
GSM549116patient 072, normal, homogenized [OPG study]7.6587678
GSM549120patient 078, normal, homogenized [OPG study]7.3844376
GSM549131patient 030, cancer, homogenized [OPG study]9.2288290
GSM549118patient 074, normal, homogenized [OPG study]8.3840484
GSM549129patient 027, cancer, homogenized [OPG study]8.9088789
GSM549123patient 088, normal, homogenized [OPG study]7.5124777
GSM549124patient 006, cancer, homogenized [OPG study]8.3801485
GSM549126patient 015, cancer, homogenized [OPG study]7.769679
GSM549128patient 025, cancer, homogenized [OPG study]9.2814691
GSM549103patient 117, normal, homogenized [OPG study]7.2222375
GSM549117patient 073, normal, homogenized [OPG study]6.3332464
GSM549138patient 041, cancer, homogenized [OPG study]9.299191
GSM549141patient 045, cancer, homogenized [OPG study]9.0131888
GSM549130patient 028, cancer, homogenized [OPG study]8.8640389
GSM549101patient 111, normal, homogenized [OPG study]7.909781
GSM549105patient 128, normal, homogenized [OPG study]7.915281
GSM549106patient 134, normal, homogenized [OPG study]10.781996
GSM549112patient 048, normal, homogenized [OPG study]7.6236478
GSM549125patient 011, cancer, homogenized [OPG study]8.3716485
GSM549127patient 024, cancer, homogenized [OPG study]8.6084786
GSM549135patient 035, cancer, homogenized [OPG study]8.0379380